What Utah’s Clinical AI Sandbox Reveals About Independent Oversight

Utah became the first state to authorize an AI sandbox for prescription renewals, but a transparency audit of the pilot found that neither the participating company nor the state would release the underlying safety data, performance metrics, or adverse event reports, with operational metrics classified as protected trade secrets. Because a regulatory framework cannot rely on a company as the sole source of safety evidence, the authors propose a Registry of Independent AI Auditors that would mandate external evaluation as a condition of sandbox participation while preserving commercial confidentiality.